STIM: Neuronetics, Inc. Common Stock Company Profile & Statistics

About

Neuronetics, Inc. is a commercial-stage medical device company. It focused on designing, developing, and marketing products for patients who suffer from psychiatric disorders. NeuroStar Advanced Therapy System(R), is the transcranial magnetic stimulation treatment for depressive disorder. Neuronetics, Inc. is based in Malvern, United States.

Info & Links

CEO

Keith J. Sullivan

Headquarters

3222 PHOENIXVILLE PIKE
MALVERN, PA 19355, UNITED STATES

Auditor

KPMG LLP

Share holders

Employees

716

Neuronetics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

251.83M

Enterprise Value

285.95M

Enterprise Value/EBITDA(ttm)

-7.88

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

2.00

Price to Book(mrq)

15.51

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

66.26%

Operating Margin(ttm)

-44.00%

Profit Margin(ttm)

-56.92%

Return on Equity(ttm)

-141.24%

Return on Invested Capital(ttm)

-67.05%

Return on Assets(ttm)

-32.77%

Income Statement

Revenue(ttm)

89.45M

Revenue Per Share(ttm)

1.36

Gross Profit(ttm)

56.81M

EBITDA(ttm)³

-36.29M

Net Income Available to Common(ttm)

-48.51M

Diluted EPS(ttm)

-1.23

Share Statistics

Beta (5Y Monthly)

2.17

52-Week Change

87.87%

S&P 500 52-Week Change

9.20%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

65.82M

Dividend Yield

0.00%

Float⁴

27.37M

% Held by Insiders

9.80%

% Held by Institutions

53.59%

Balance Sheet

Total Cash(mrq)

21.43M

Total Cash Per Share(mrq)

0.33

Total Debt(mrq)

55.34M

Total Debt/Equity(mrq)

139.99%

Current Ratio(mrq)

2.44%

Quick Ratio(mrq)

2.87%

Book Value Per Share(mrq)

0.60

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.28

Free Cash Flow(ytd)

-17.21M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

STIM

Neuronetics, Inc. Common Stock

Neuronetics, Inc. Common Stock Profile